Nutranomics Stock Performance
The company secures a Beta (Market Risk) of 0.0, which conveys not very significant fluctuations relative to the market. the returns on MARKET and Nutranomics are completely uncorrelated.
Risk-Adjusted Performance
12 of 100
Weak | Strong |
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Nutranomics are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Nutranomics showed solid returns over the last few months and may actually be approaching a breakup point. ...more
Nutranomics |
Nutranomics Relative Risk vs. Return Landscape
If you would invest 0.00 in Nutranomics on September 14, 2024 and sell it today you would earn a total of 0.00 from holding Nutranomics or generate 0.0% return on investment over 90 days. Nutranomics is currently generating 28.5714% in daily expected returns and assumes 178.1885% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Nutranomics, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Nutranomics Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Nutranomics' investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Nutranomics, and traders can use it to determine the average amount a Nutranomics' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1603
| Best Portfolio | Best Equity | NNRX | ||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 178.19 actual daily | 96 96% of assets are less volatile |
Expected Return
| 5.01 actual daily | 96 96% of assets have lower returns |
Risk-Adjusted Return
| 0.16 actual daily | 12 88% of assets perform better |
Based on monthly moving average Nutranomics is performing at about 12% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Nutranomics by adding it to a well-diversified portfolio.
Nutranomics Fundamentals Growth
Nutranomics Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Nutranomics, and Nutranomics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Nutranomics Pink Sheet performance.
| Return On Asset | -1.72 | |||
| Current Valuation | 1.23 M | |||
| Shares Outstanding | 580.67 M | |||
| Price To Sales | 0.01 X | |||
| EBITDA | (1.22 M) | |||
| Cash And Equivalents | 34 | |||
| Total Debt | 3.45 M | |||
| Book Value Per Share | (0) X | |||
| Cash Flow From Operations | (570.27 K) | |||
| Total Asset | 408 K | |||
| Retained Earnings | (6.85 M) | |||
| Current Asset | 394 K | |||
| Current Liabilities | 2.56 M | |||
About Nutranomics Performance
Evaluating Nutranomics' performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Nutranomics has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Nutranomics has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Nutranomics, Inc. engages in the research, development, and sale of nutritional food products. The company was founded in 1995 and is headquartered in Salt Lake City, Utah. Nutranomics operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 1 people.Things to note about Nutranomics performance evaluation
Checking the ongoing alerts about Nutranomics for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Nutranomics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Nutranomics is way too risky over 90 days horizon | |
| Nutranomics has some characteristics of a very speculative penny stock | |
| Nutranomics appears to be risky and price may revert if volatility continues | |
| Nutranomics has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (950.79 K) with loss before overhead, payroll, taxes, and interest of (407). | |
| Nutranomics currently holds about 34 in cash with (570.27 K) of positive cash flow from operations. |
- Analyzing Nutranomics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Nutranomics' stock is overvalued or undervalued compared to its peers.
- Examining Nutranomics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Nutranomics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Nutranomics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Nutranomics' pink sheet. These opinions can provide insight into Nutranomics' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Nutranomics Pink Sheet Analysis
When running Nutranomics' price analysis, check to measure Nutranomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nutranomics is operating at the current time. Most of Nutranomics' value examination focuses on studying past and present price action to predict the probability of Nutranomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nutranomics' price. Additionally, you may evaluate how the addition of Nutranomics to your portfolios can decrease your overall portfolio volatility.